Having in mind the facts around cancer, the chilean government has promoted the clinical trials development to face the challenges around this disease. In the last year, 76 protocols / clinical trials have been approved, of which 22% are related to lung cancer, 14% prostatic cancer, 10% malignant melanoma, 9% kidney cancer, and 6% gastric cancer. Saga represents the effort of a group of professionals with broad experience in oncological clinical trials understanding the need of providing an alternative to cancer patients seeking the best way to match the clinical trials with them. For this reason, Saga has established an important network with the oncological community in the country. Saga represents an interesting and attractive partner for the development of oncological clinical trials not only in the Chile but also in Latin America.